Biomarck is pleased to announce its inclusion on COVID-19 Drug Treatment Trackers: Milken Institute COVID-19 Treatment and Vaccine Tracker | Artis Ventures

Dr. Guillermo De Angulo


Dr. De Angulo received his medical degree at the Escuela de Ciencias Medicas/Universidad Autonoma de Centro America in San Jose, Costa Rica. He completed his residency in pediatrics at Driscoll Children’s Hospital/Texas A&M University College of Medicine and a fellowship in pediatric hematology-oncology at the University of Texas M. D. Anderson Cancer Center in Houston, Texas. During his fellowship, he was awarded the Young Investigator Travel Award by the American Society of Pediatric Hematology Oncology. Dr. De Angulo is board certified in pediatrics and pediatric hematology-oncology. Dr. De Angulo actively participates in research. He has published and has presented research outcomes at numerous national and international conferences.

His interests are in administering targeted therapies for children with high-risk malignancies and providing the latest cutting edge therapies in a safe and family-centered environment. He specializes in treating children with particularly difficult or relapsed forms of pediatric cancer.

Dr. De Angulo is in collaboration with Dr. Regina Graham at the University of Miami. Her laboratory is focusing on creating a delivery mechanism for brain tumors utilizing nanoparticles with carbon dots (C-dots). This is a non-toxic and effective mechanism to bypass the blood brain barrier and deliver chemotherapy. The laboratory is also directed at understanding the effects of critical pathways that contribute to the growth and proliferation of neuroblastoma. Many of Dr. De Angulo’s residents volunteer their time in doing basic science research in the laboratory and present their findings in national and international conferences